SEC Form D private-offering filing

REVO Oncology Diagnostics Inc.

Name: REVO Oncology Diagnostics Inc. - new SEC Form D private-offering filing, Frisco, TX
Published: 2026-04-13

A new SEC Form D private-offering notice from Frisco, TX, a $1,200,000 filer-stated offering target in Biotech. The source filing is one click away.

REVO Oncology Diagnostics Inc. site↗ Verified via SEC Form D

Developer of Chemo Select, a genomic platform that predicts which chemotherapies a cancer patient will respond to before treatment begins.

Filed 2026-04-13Filed to raise $1,200,000First money in 2025-09-17Raised so far $270,000HQ (as filed) Frisco, TXSector Biotech ✓Stage (inferred) SeedCall status Late filing

Source linked the Form D on EDGAR↗Website verified revooncology.com↗Named in the filing 1 executive & director

Open this row on the live feed →More new filings in Texas →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.